New look, promotions at Choreo Market Access
Choreo Market Access has a new brand and two new leaders. The agency’s parent, The Healthcare Consultancy Group (HCG), a division of the DAS Group of Companies, announced the changes this week.
“Market access, the discipline of defining and communicating the unique value of medications and medical devices in order to facilitate their prescribing and use, is a necessity in today’s rapidly changing healthcare marketplace,” executives say. “Choreo Market Access addresses this need by providing clients a comprehensive suite of services that can be tailored to meet their needs throughout a brand’s lifecycle. These services include strategic consulting; market research and analytics; branding; data visualization and information design; payer marketing; provider and patient access and reimbursement support; and payer public relations.”
The agency was founded in June 2015 as Guarino Haskins Market Access. According to Roger Haskins, founder and executive creative director, “Our vison is a world where people have access to the healthcare they need and this vision inspired us to evolve our brand to Choreo Market Access. We are an agency that brings strategy and creative together for access success.”
Kimberly Rawlins has been promoted to senior VP, director of strategic services, and Diana Maldonado to senior VP, direcoro of client services.
Kimberly Rawlins
In addition to leading content development, Rawlins will now oversee medical and integrated strategy. She has over 17 years of comprehensive pharmaceutical and biotech experience in the manufacturer space. Having worked in sales, sales leadership, and brand and payer marketing, executives say Rawlins is an expert in the development and implementation of strategic marketing plans for the launch and sustained performance of products, including developing payer brand plans, creating suites of launch materials, and implementing sales strategies and tactics.
“At Choreo, Rawlins contributes not only with a well-honed perspective on the access and reimbursement issues facing manufacturers, providers and patients, but also with leadership skills, which stem from her confidence in the agency and its mission,” executives say.
Maldonado will now lead the project management team in addition to account services. Executives say she is as experienced with agency operations as she is with client services, financial management, and the strategically nuanced content of market access. Her client work spans the pharmaceutical and biotechnology industries and has covered numerous therapeutic categories including oncology, nephrology, rheumatology, infectious disease, and cardiology.
“Skilled at successfully integrating market access marketing teams with clients’ professional, patient and digital agencies, Maldonado has mastered allocating resources effectively and efficiently, such as when she led six product/indication launches and executed tactics to the field within a week of the Prescription Drug User Fee Act (PDUFA) date,” executives say.
“At Choreo, we have a team of experts who address some of the most critical issues our clients face today—issues of access and reimbursement,” says Denise Bottiglieri, PhD, CEO of HCG. “This group’s ability to transform complex information into messages that are simple, memorable, and actionable complements HCG’s expertise in marketing, medical professional, and regulatory communications.”
For more information on Choreo Market Access, contact Roger Haskins at
[email protected] or visit choreomarketaccess.com.
